Clinical trial
Risk Reduction of Symptomatic and Silent Brain Infarctions During Cardiac Surgery Due to Ultrasound Activation of Endogenous Fibrinolytic System Using Transcranial Doppler Monitoring
NCT01591018 is registered in ClinicalTrials.gov with University Hospital Ostrava as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Risk Reduction of Symptomatic and Silent Brain Infarctions During Cardiac Surgery Due to Ultrasound Activation of Endogenous Fibrinolytic System Using Transcranial Doppler Monitoring
- Lead sponsor
- University Hospital Ostrava
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2012
- Completion date
- July 31, 2015
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery bypass graft redo, heart valve diseases